Early cancer-detection startup Grail is reportedly trying to raise more money

 Just months after Grail raised a $900 million Series B round, the startup that aims to detect cancer early on is looking for additional funding, CNBC reports. Prior to the $900 million round, Grail raised $100 million last year to develop initial studies of its blood test technology. Read More

Responses are currently closed, but you can trackback from your own site.

Comments are closed.